News | Radiation Dose Management | March 06, 2019

Associations remind general public that danger from irradiated remains is minimal

AAPM and ACR Address JAMA Article on Radioactive Material in Cremated Bodies

March 6, 2019 — A recent Journal of the American Medical Association (JAMA) publication1 describing the cremation of patient remains containing a radioactive material garnered considerable media attention and may have alarmed some members of the general public.

The American Association of Physicists in Medicine (AAPM) and the American College of Radiology (ACR) released a series of key points to put the topic into better perspective.

The associations want the general public to know:  

  • Radioactive materials are used routinely in medical practice to improve human health;

  • The risk of harm to the crematorium operator is so small that it cannot be measured;

  • Consensus guidelines from national (CDC and DOE) international radiation protection and public health organizations provide clear guidance on how to identify radioactivity in patient remains and appropriately deal with the body of the decedent;  

  • Healthcare providers who administer radioactive material must have a designated Radiation Safety Officer whose credentials meet criteria established by the U.S. Nuclear Regulatory Commission (A and B), the federal agency that regulates the use of radioactive materials. These individuals are often certified medical physicists or health physicists; and

  • The low-cost best practice of installing a simple radiation detector in hospital morgues, funeral homes and crematoriums would quickly alert staff to the presence of radioactivity. A certified medical physicist or health physicist has the expertise to determine when the measured radiation levels will have decreased to a level where it is safe to release the body to coroners, medical examiners or mortuary services.

For more information:,


1. Yu N.Y., Rule W.G., Sio T.T., et al. Radiation Contamination Following Cremation of a Deceased Patient Treated with a Radiopharmaceutical. JAMA. 2019;321(8):803-804.

Related Content

News | Mammography

May 6, 2024 — Enable Me, a VELA Medical company, cited major new research by Siemens Healthineers entitled, “The future ...

Time May 06, 2024
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time September 20, 2023
News | Digital Radiography (DR)

May 18, 2023 — Carestream Health’s new, versatile DRX-LC Detector is designed to improve patient comfort, image quality ...

Time May 18, 2023
News | Radiation Oncology

May 18, 2023 — Cassling announced it is a new strategic sales agent in various geographic territories across the United ...

Time May 18, 2023
News | Artificial Intelligence

March 10, 2023 — Computed tomography (CT) is one of the most powerful and well-established diagnostic tools available to ...

Time March 10, 2023
Feature | ASTRO | Christine Book

The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the American Society for ...

Time January 13, 2023
News | Interventional Radiology

October 28, 2022 — Radiaction Medical, Ltd, a medical device innovator dedicated to providing healthcare physicians and ...

Time October 28, 2022
News | Quality Assurance (QA)

October 7, 2022 — Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and ...

Time October 07, 2022
News | ASTRO

The 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO) will take place October 23-26, at the ...

Time September 29, 2022
Subscribe Now